Nanomedicine: An Essential Resource in Treatment and Diagnosis of Viral Diseases
The recent outbreak of COVID-19 is considered to be one of the biggest disasters faced in the history which has already killed 211568 and effected 3065739 people across the world (As on 28th April 2020). Thus, there is an alarming need to discuss novel treatment strategies for treatment of such viral outbreaks. Viral diseases affect millions of people around the world, with a major effect on human health and socio-economic development. The human immunodeficiency virus (HIV) affects more than 40 million people alone. This analysis examines the different nanocarriers (e.g. liposomes, solid lipid nanoparticles, polymeric nanoparticles, etc.) based on methods implemented in the literature and in the clinic to address the numerous challenges faced by the antiviral therapy. This review includes recent strategy devised using Nanomedicine to treat H1N1 Influenza virus. In this review we also tried to discuss few viruses which help in cancer therapy including recent developments in treatment of COVID-19 using Nanotechnology.
COVID-19 , H1N1 , Nanomedicine , HIV , SARS
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.